Editorial: FDA commissioner targeting celebrity endorsements

Notes

• Maharashtra FDA Commissioner is targeting celebrity endorsements of products suspected of being surrogate advertisements for tobacco.
• The core issue involves the 'gross asymmetry' where celebrities gain from endorsements while consumers bear the health risks.
• Legal framework: Cigarettes and Other Tobacco Products Act (COTPA) Rules, Food Safety and Standards Act 2006, and Consumer Protection Act 2019.
• Delhi High Court (DGHS vs Som Pan Product Pvt. Ltd., 2024) ruled that the state bears the burden of proof to establish surrogate advertising.
• Consumer Protection Act 2019 introduced endorser liability, limiting the 'ignorance' defense for celebrities.
• India faces the world's largest burden of oral cancer, necessitating stricter regulation of unfair trade practices in advertising.
• Regulatory challenges include a fragmented legal regime across multiple Acts and the potential for regulatory overreach.

Part of a longer story

This is day 2 of 2 in Maharashtra FDA crackdown on celebrity surrogate advertising, which has been running since 17 August 2026. Reading it whole is usually worth more than reading today alone — the exam asks how something developed.

• FDA notice to actors for surrogate advertising Before
• The whole story 2 entries